Aptose Biosciences, Inc.
APTO
APTO was delisted on the 1st of April, 2025.
9 hedge funds and large institutions have $6.16M invested in Aptose Biosciences, Inc. in 2016 Q2 according to their latest regulatory filings, with 1 funds opening new positions, 1 increasing their positions, 2 reducing their positions, and 3 closing their positions.
18% less funds holding
Funds holding: 11 → 9 (-2)
20% less capital invested
Capital invested by funds: $7.73M → $6.16M (-$1.57M)
50% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 2
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$16.5K |
| 2 |
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
+$2.36K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CAM
Cormorant Asset Management
Boston,
Massachusetts
|
-$240K |
| 2 |
BBA
Baker Bros. Advisors
New York
|
-$100K |
| 3 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
-$8.26K |
| 4 |
UBS Group
Zurich,
Switzerland
|
-$8K |
| 5 |
Bank of America
Charlotte,
North Carolina
|
-$3K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
1
Franklin Resources
San Mateo,
California
| $3.51M | – | – | – |
|
|
CAM
2
Cormorant Asset Management
Boston,
Massachusetts
| $2.42M | -$240K | -203 | -8% |
|
3
Bank of Montreal
Toronto,
Ontario, Canada
| $128K | – | – | – |
|
|
CC
4
Callan Capital
La Jolla,
California
| $29K | – | – | – |
|
|
KCM
5
Knoll Capital Management
Miami,
Florida
| $29K | – | – | – |
|
|
6
Royal Bank of Canada
Toronto,
Ontario, Canada
| $27K | -$8.26K | -7 | -22% |
|
|
7
Morgan Stanley
New York
| $18K | +$16.5K | +14 | +700% |
|
|
TRCT
8
Tower Research Capital (TRC)
New York
| $3K | – | – | – |
|
|
9
Deutsche Bank
Frankfurt Am Main Ge,
Germany
| $2K | +$2.36K | +2 | New |
|
|
SIM
10
Sonora Investment Management
Tucson,
Arizona
| $20 | – | – | – |
|
|
BBA
11
Baker Bros. Advisors
New York
| – | -$100K | -74 | Closed |
|
|
12
UBS Group
Zurich,
Switzerland
| – | -$8K | -6 | Closed |
|
|
13
Bank of America
Charlotte,
North Carolina
| – | -$3K | -2 | Closed |
|
APTO Hedge Fund Activity: Q2 2016 in Review
9 of the 3,748 institutional investors tracked by Wall St. Rank reported a position in Aptose Biosciences, Inc. (APTO) for Q2 2016, worth a combined $6.16M — down 20% from $7.73M a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of APTO and 1 opened new positions — a net loss of 2 holders — while 2 trimmed existing stakes and 1 added.
The largest buyer was Morgan Stanley, adding an estimated $16.5K. The largest seller was Cormorant Asset Management, cutting an estimated $240K.
- 9 institutional investors held Aptose Biosciences, Inc. (APTO) as of Q2 2016, down from 11 in Q1 2016.
- Funds reported $6.16M of Aptose Biosciences, Inc. stock for Q2 2016, down 20% quarter-over-quarter.
- 1 fund opened new Aptose Biosciences, Inc. positions in Q2 2016 and 3 closed out, a net change of -2 holders.
- The largest Aptose Biosciences, Inc. buyer in Q2 2016 was Morgan Stanley, an estimated $16.5K added.
- The largest Aptose Biosciences, Inc. seller in Q2 2016 was Cormorant Asset Management, an estimated $240K sold.
Based on aggregated 13F filings for Q2 2016.